Skip to content
Screener

Total Revenue at other companies

Emergent Biosolutions logo
Emergent BiosolutionsEBS
$234.3M+66.3%
Opko Health logo
Opko HealthOPK
$163.58M+4.3%
Merck & Co. logo
Merck & Co.MRK
$16.61B+5.1%
Septerna, Inc. logo
Septerna, Inc.SEPN
$26.75M+22,376%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$6.23M-96.1%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$1B-2.7%

Segments

By geography

See full
US$28.03M-65.4%
Asia Pacific$12.7M
EMEA$272.54K
CA$0

By segment

See full
Single Reportable$41M-49.5%

Other financials

Income statement

See full
Gross profit$23.4M-57.8%
Operating income$13.9M-69.6%
Net income$12.5M-64.9%
EPS (diluted)$0.17-65.3%

Balance sheet

See full
Cash & equivalents$117.6M-35.6%
Total debt$439.4K-58.8%
Total equity$165.3M-21.0%
Total assets$175.7M-25.3%

Cash flow

See full
Operating cash flow$15.2M-75.9%
CapEx--100%
Free cash flow$15.2M-75.9%

Valuation

See full
Market cap$214.11M-66.7%
Enterprise value$96.97M-79.0%
P/E5.6×+2.0×
P/S+0.4×

Profitability

See full
Gross margin54.4%-22.6pp
Operating margin52.4%-7.8pp
Net margin43.2%-6.1pp
FCF margin66.2%

Returns & leverage

See full
Return on equity39.9%-18.5pp
Debt / equity0.0×
Current ratio21.7×+11.6×

Where this comes from

Reported directly by SIGA Technologies in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: SIGA Technologies’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:46 PM EDT
Fiscal quarter
Q4 FY2026
Calendar quarter
Q4 2026
Accession
0001437749-26-026314
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenues
Product sales and supportive services$37,870,335$79,124,860$41,408,212$84,946,107
Research and development3,131,9181,995,1445,836,6223,214,711
Total revenues41,002,25381,120,00447,244,83488,160,818
Operating expenses
Cost of sales and supportive services17,561,18525,554,46220,502,06925,712,200
Selling, general and administrative5,148,9925,487,5769,822,00511,163,238
Research and development4,386,4984,398,0978,336,3447,860,910

Item 1 - Condensed Consolidated Financial Statements

FAQ

What is SIGA Technologies's total revenue?
SIGA Technologies (SIGA) reported total revenue of $41M in Q2 2026.
How has SIGA Technologies's total revenue changed year-over-year?
SIGA Technologies's total revenue decreased by 49.5% year-over-year, from $81.12M to $41M.
What is the long-term trend for SIGA Technologies's total revenue?
Over 4 years (2021 to 2025), SIGA Technologies's total revenue has grown at a -8.3% compound annual growth rate (CAGR), from $133.67M to $94.57M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about SIGA Technologies's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude